Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Vomiting 6Nausea 3Neoplasms 2Uterine Neoplasms 1Testicular Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Ovarian Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Multiple Myeloma 1Melanoma 1Gynecologic Cancer 1Gastrointestinal Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Ifosfamide 10Carboplatin 8Paclitaxel 7Etoposide 7Filgrastim 5Dexamethasone 3Cisplatin 3Thiotepa 2Stem Cell Transplantation 2Peripheral Blood Stem Cell Transplantation 2Oxaliplatin 2Ondansetron 2Mesna 2Melphalan 2Granulocyte Colony-Stimulating Factor 2Cyclophosphamide 2Calcium Dobesilate 2Bleomycin 2Aprepitant 2tremelimumab 1thymoglobulin 1sodium thiosulfate 1poly ICLC 1pembrolizumab 1pegfilgrastim 1palifosfamide lysine 1palbociclib 1isophosphamide mustard 1fosaprepitant 1etoposide phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Testicular Neoplasms × fosaprepitant × Clear all
NCT01736917 2016-05-25

Fosaprepitant + 5HT3 Receptor Antagonists + Dexamethasone in Germ Cell Tumors

Hoosier Cancer Research Network

Phase 2 Completed
65 enrolled 14 charts
Genitourinary

Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡